Description
This is a measure of the percentage of hip fracture patients who were given bone protection medication within 120 days after admission.
Measure set
Notes about this measure set
Numerator
The number of people with a hip fracture who were given bone protection medication within 120 days after admission.
Denominator
The Australian & New Zealand Hip Fracture Registry population.
Denominator detail
Hip fracture patients who had ‘yes – bisphosphonates, strontium, denosumab or teriparatide (with or without calcium and/or vitamin D)’ entered for the question on whether they had been given bone protection medication in the Australian & New Zealand Hip Fracture Registry.
Denominator exclusions
People who had no value or 'null’ recorded for the bone protection medication question in the registry.
Responsible organisation(s)
Data sources